Evogene Financial Overview
Evogene's market cap is currently $9.41M. The company's EPS TTM is $0.444; its P/E ratio is -2.13; Evogene is scheduled to report earnings on November 20, 2025, and the estimated EPS forecast is $-0.26. See an overview of income statement, balance sheet, and cash flow financials.
